Targeted therapies: peaking beneath the surface of recent bevacizumab trials

Nat Rev Clin Oncol. 2011 Jun;8(6):319-20. doi: 10.1038/nrclinonc.2011.66. Epub 2011 Apr 19.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Clinical Trials as Topic
  • Female
  • Humans
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents